Ms. Onifade leads one of the largest integrated cancer programs in the nation, overseeing a multibillion-dollar enterprise that treats more than 50,000 new cancer patients annually across 130-plus sites in five states with over 750 affiliated physicians. She is unifying clinical operations, research, education, innovation and commercialization into a cohesive national strategy, embedding clinical trials into care delivery, standardizing patient access, and integrating AI and emerging technologies to improve outcomes and efficiency. Previously, as division vice president at Chicago-based CommonSpirit Health, she managed a $250 million oncology division, driving a 30% net revenue increase in two years, expanding access to over 220 clinical trials, launching CAR T-cell therapy and improving staff retention by 55%. Her earlier leadership at Pittsburgh-based UPMC included integrating community cancer programs into the UPMC Hillman Cancer Center to expand subspecialty and clinical trial access. She is nationally recognized as a 2025 “Outstanding Diversity Champion” by the Houston Business Journal, a 2024 Diversity MBA “Top 100 Under 50 Executive Leader” and a 2024 “Thomas C. Dolan Executive Leadership Scholar” according to the American College of Healthcare Executives.
